The latest news about Lumendi
November 5, 2025
| DiLumen | DiLumen C¹ | DiLumen EZ¹ | EZ-Glide | Homepage | News | Press Release
LUMENDI RECEIVES CE MARK FOR DILUMEN™ EZ¹ AND DILUMEN™ C¹, EXPANDING FOOTPRINT IN THE EUROPEAN MARKET
This certification is a key milestone in our global strategy to expand access to minimally invasive endoluminal procedures
October 31, 2025
| DiLumen | DiLumen C¹ | DiLumen EZ¹ | News | Press Release
LUMENDI RECEIVES CE MARK FOR DILUMEN™ EZ¹ AND DILUMEN™ C¹, EXPANDING FOOTPRINT IN THE EUROPEAN MARKET
LUMENDI RECEIVES CE MARK FOR DILUMEN™ EZ¹ AND DILUMEN™ C¹, EXPANDING FOOTPRINT IN THE EUROPEAN MARKET ZUG, Switzerland, Oct. 29, 2025 /PRNewswire/ Lumendi AG, a leader in advanced endoluminal technologies, today… Continue reading LUMENDI RECEIVES CE MARK FOR DILUMEN™ EZ¹ AND DILUMEN™ C¹, EXPANDING FOOTPRINT IN THE EUROPEAN MARKET
May 31, 2025
| DiLumen | News | Press Release
Untitled
Lumendi shines at TxIEG 2025, a record-breaking year for the company with unprecedented interest in the DiLumen Endoluminal Interventional Platform.
February 1, 2025
| endoscopic | Homepage | News | Press Release
Lumendi Continues Training Future GI Leaders Through Long-Standing Industry Collaboration
February 1, 2025: Lumendi once again participated in the Advanced Hands-On Therapeutic Endoscopy Course, a quarterly training program led by Dr. Sergey Kantsevoy at the Institute for Digestive Health and… Continue reading Lumendi Continues Training Future GI Leaders Through Long-Standing Industry Collaboration
November 19, 2024
| Homepage | News | Press Release
Lumendi Supports Advanced Gastroenterology Training at the Florida Third Space Endoscopy Workshop
Lumendi sponsored the Florida Third Space Endoscopy Workshop from November 17-19, 2024, at the AdventHealth Nicholson Center, emphasizing its commitment to advancing gastroenterology training. Participants had the opportunity to enhance their skills in Endoscopic Submucosal Dissection (ESD) techniques through hands-on sessions with Lumendi’s innovative interventional platforms.
September 10, 2024
| Homepage | News | Press Release
Demonstrating Significant Time and Cost Savings in Colorectal ESD
The prospective, randomized controlled study found that DiLumen reduced total procedure time by 36.5%, leading to an average cost savings of $610.16 per patient.
July 27, 2023
| DiLumen EZ¹ | Grasper | Homepage | News | Press Release
EZ¹ successfully completes Customer Evaluation phase.
Lumendi Achieves Key Milestone with Completion of DiLumen EZ¹ Customer Evaluations, Setting the Stage for the Next Phase of DiLumen Product Innovation WESTPORT, CT – July 27, 2023 Lumendi, a… Continue reading EZ¹ successfully completes Customer Evaluation phase.
July 1, 2023
| News | Press Release | Products
A Randomized Prospective Study Evaluating Effectiveness Of A Double Balloon Endolumenal Platform For Colorectal EndoscopicSubmucosal Dissection
Endoscopic removal of colonic polyps and early cancers eliminates the need for surgical resection and possible temporary or permanent colostomy.
April 20, 2023
| News | Press Release
Dr. Roberta Maselli, receives innovation of the year award for the best new device from the ESGE
Award for the Balloon Endo-Luminal Lumen Occluding (BELLO) Device Presented to Dr. Maselli at the ESGE Days 2023 Congress Apr 20, 2023, 12:27 ET Lumendi Congratulates Dr. Maselli on the… Continue reading Dr. Roberta Maselli, receives innovation of the year award for the best new device from the ESGE
February 16, 2023
| DiLumen C¹ | Grasper | News | Press Release | Products
Lumendi Receives 510(k) Clearance for Two New Devices
Company Achieves New Milestone with Over 4,000 Therapeutic Procedures Completed Across the U.S., Europe and Asia, Using DiLumen™ Endoluminal Interventional Platform February 16, 2023 08:00 AM Eastern Standard Time WESTPORT,… Continue reading Lumendi Receives 510(k) Clearance for Two New Devices
| Homepage | News | Press Release | Uncategorized
Lumendi receives 510k clearance for two new devices
Lumendi receives 510k clearance for two new devices Company Achieves New Milestone with Over 4,000 Therapeutic Procedures Completed Across the U.S., Europe and Asia, Using DiLumen™ Endoluminal Interventional Platform February… Continue reading Lumendi receives 510k clearance for two new devices
May 22, 2022
| Press Release
Lumendi Files for 510(k) Clearance for Two New Products
Company Achieves New Milestone with 3,000 Therapeutic Procedures Completed Across U.S., Europe, and Asia Using DiLumen™ EIP DiLumen EZ¹ single balloon stabilization endotherapy device. (Photo: Business Wire) May 19, 2022… Continue reading Lumendi Files for 510(k) Clearance for Two New Products
| News | Press Release
Lumendi Files for 510(k) Clearance for Two New Products
Company Achieves New Milestone with 3,000 Therapeutic Procedures Completed Across U.S., Europe, and Asia Using DiLumen™ EIP DiLumen EZ¹ single balloon stabilization endotherapy device. (Photo: Business Wire) May 19, 2022… Continue reading Lumendi Files for 510(k) Clearance for Two New Products
February 10, 2022
| Homepage | News | Press Release
Lumendi Reports Successful Completion Of Dilumen™ Eip First-in-human Trials
LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS Primary Study Endpoint Reached with no Serious Adverse Events WESTPORT, CONNECTICUT, November 16, 2017 – Connecticut-based medical device innovator Lumendi,… Continue reading Lumendi Reports Successful Completion Of Dilumen™ Eip First-in-human Trials
September 28, 2021
| News | Press Release | Uncategorized
EZ Glide Pushes Lumendi to New Quarter-Over-Quarter Sales Record
DiLumen® Product Enhancement Launched in December 2020 on Track to Double Sales from Previous Year September 28, 2021 WESTPORT, Conn.--(BUSINESS WIRE)-- EZ Glide, the most recent enhancement to Lumendi’s DiLumen Endoluminal Interventional… Continue reading EZ Glide Pushes Lumendi to New Quarter-Over-Quarter Sales Record
March 29, 2021
| Homepage | News | Press Release | Uncategorized
Lumendi Introduces EZ Glide Hydrophilic Coating for Its DiLumen Endoluminal Interventional Platform (EIP™)
Lumendi Platforms to be Discussed in Investor’s Webcast 31 March 2021 with Panel of Clinical Experts New EZ Glide, activated by water or saline, improves endoscopic performance of the DiLumen… Continue reading Lumendi Introduces EZ Glide Hydrophilic Coating for Its DiLumen Endoluminal Interventional Platform (EIP™)
January 6, 2021
| News | Press Release
DiLumen online
Online Support for Clinical Cases With the current restrictions travel and in-house visits are often limited or impossible. The Lumendi team will continue to support you with the use of… Continue reading DiLumen online
| Events | News | Press Release
ASGE Webinar Online
Upcoming ASGE Webinar: Navigating the Tortuous Colon Reimbursement for Complex Endoscopic Resection January 14th at 8pm EST (7pm CST) Join ASGE staff and Dr. Othman as they cover the following:… Continue reading ASGE Webinar Online
August 12, 2020
| News | Press Release
PIONEERING ENDOSURGERY NEW MISSION STATEMENT AT LUMENDI
Pioneering Endosurgery reflects Lumendi’s innovative, three-part pathway to:
expand indication areas and procedures in the upper gastrointestinal tract, which includes a recent submission to the FDA;
innovate improvements planned for the DiLumen EIP, including a proprietary lubricated inner surface of DiLumen’s sheath for better endoscope handling performance; and
commercially release the DiLumen C2 platform[1] to bring robotic-like end-effectors to endolumenal surgery in a low-cost, disposable format to provide endoscopists with unprecedented control of tissue.
June 1, 2020
| Press Release
LUMENDI REPORTS FIRST INCISIONLESS APPENDECTOMY USING DOUBLE-BALLOON ENDOLUMENAL INTERVENTIONAL PLATFORM
Dr. Kantsevoy states, “Endoscopic endolumenal appendectomy is less invasive than traditional surgical, laparoscopic, transvaginal or transgastric appendectomy.
May 28, 2020
| Press Release
Early Trial Data Show Promise in Endoscopic Procedure Time Study
A study evaluating endoscopic procedure time removing complex colorectal polyps shows superiority of Lumendi’s DiLumen device over a control group.
March 26, 2020
| Press Release
LUMENDI OPERATIONS AND CLINICAL SUPPORT REMAIN AVAILABLE DURING OBSERVANCE OF COVID-19 PRECAUTIONS.
We have adapted our operation and clinical support models as healthcare facilities prioritize focus on patients affected by COVID-19.
March 25, 2020
| Press Release
LUMENDI REPORTS SUCCESSFUL ENROLLMENT CLOSURE OF ITS DILUMEN™ ENDOLUMENAL INTERVENTIONAL PLATFORM (EIP™) STUDY
The study evaluates DiLumen’s effect on endoscopic procedure time for pre-cancerous colorectal complex polypectomies.
October 21, 2019
| Press Release
LARGE COMPLEX POLYPS REMOVED SUCCESSFULLY FROM THREE PATIENTS WITHOUT SURGICAL INTERVENTION USING LUMENDI DILUMEN C2™
The first successful case at Cleveland Clinic using DiLumen C2 was completed by Dr. Gorgun when a large complex polyp in the distal sigmoid, 18cm from the anus was removed from a 72-year-old woman with a narrow sigmoid.
August 20, 2019
| Press Release | Uncategorized
LUMENDI RECEIVES 510(k) CLEARANCE FOR DILUMEN Ik™ ENDOLUMENAL INTERVENTIONAL KNIFE
1000 Therapeutic Procedures Using DiLumen™ EIP Completed Across U.S., Europe and Asia WESTPORT, CONN, August 20, 2019 − Connecticut-based medical device innovator Lumendi, LLC (http://www.lumendi.com) has announced it has received U.S.… Continue reading LUMENDI RECEIVES 510(k) CLEARANCE FOR DILUMEN Ik™ ENDOLUMENAL INTERVENTIONAL KNIFE
June 10, 2019
| News | Press Release | Uncategorized
LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN C2TM
Second Generation Endoscopic Accessory for Endolumenal Procedures WESTPORT, CONN, April 23, 2018 – Connecticut-based medical device innovator Lumendi, LLC has announced it has received United States Food and Drug Administration… Continue reading LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN C2TM
November 13, 2018
| News | Press Release
LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR INNOVATIVE DILUMEN™ EIP DEVICE MODIFICATION TO IMPROVE TISSUE RETRACTION DURING THERAPEUTIC ENDOSCOPY
With recent regulatory approvals in Europe, Lumendi has established distribution in the UK, France and Italy and has conducted successful procedures with clinicians in each country.
October 4, 2018
| News | Press Release
500 THERAPEUTIC PROCEDURES USING DILUMEN™ EIP COMPLETED ACROSS U.S., EUROPE AND ASIA
WESTPORT, CONN, OCTOBER 4, 2018 − Connecticut-based medical device innovator Lumendi, LLC reports that more than 500 therapeutic procedures by more than 40 endoscopists and colorectal surgeons have been completed… Continue reading 500 THERAPEUTIC PROCEDURES USING DILUMEN™ EIP COMPLETED ACROSS U.S., EUROPE AND ASIA
August 21, 2018
| News | Press Release | Uncategorized
LUMENDI EXPANDS TEAM WITH NEW VP OF SALES, MICHAEL R. THOMAS
WESTPORT, CT, August 21, 2018 – Connecticut-based medical device innovator Lumendi, LLC is again expanding its team as Michael R. Thomas joins as Vice President of Sales. Mr. Thomas is… Continue reading LUMENDI EXPANDS TEAM WITH NEW VP OF SALES, MICHAEL R. THOMAS
July 17, 2018
| News | Press Release
LUMENDI OPENS EU MARKET FOR DILUMEN EIP™
CE Certification Confirms Device Conforms to Medical Device Directive 93/42/EEC BUCKINGHAMSHIRE, UK, JULY 17, 2018 -- Lumendi Ltd., a privately held innovative medical device company, today announced that its subsidiary,… Continue reading LUMENDI OPENS EU MARKET FOR DILUMEN EIP™
June 14, 2018
| News | Press Release
FLEXIBLE ENDOSCOPIC DOUBLE BALLOON PLATFORM: FROM CONCEPT TO HUMAN FEASIBILITY TRIAL
Flexible Endoscopic Double Balloon Platform: from concept to human feasibility trial. Sam Sharma*, Kota Momose, Toyooki Sonoda, Reem Z. Sharaiha Weill Cornell Medical College, New York, NY Background: Despite the… Continue reading FLEXIBLE ENDOSCOPIC DOUBLE BALLOON PLATFORM: FROM CONCEPT TO HUMAN FEASIBILITY TRIAL
May 29, 2018
| News | Press Release | Uncategorized
LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN Is™ ENDOLUMENAL INTERVENTIONAL SCISSORS
Second Generation Endoscopic Accessory for Endolumenal Procedures WESTPORT, CONN, May 29, 2018 − Connecticut-based medical device innovator Lumendi, LLC has announced it has received United States Food and Drug Administration… Continue reading LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN Is™ ENDOLUMENAL INTERVENTIONAL SCISSORS
April 24, 2018
| News | Press Release | Uncategorized
LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN C2TM
Second Generation Endoscopic Accessory for Endolumenal Procedures WESTPORT, CONN, April 23, 2018 – Connecticut-based medical device innovator Lumendi, LLC has announced it has received United States Food and Drug Administration… Continue reading LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN C2TM
December 6, 2017
| News | Press Release | Uncategorized
DILUMEN™ EIP COMPLETES 100 THERAPEUTIC PROCEDURES ACROSS UNITED STATES
DILUMEN™ EIP COMPLETES 100 THERAPEUTIC PROCEDURES ACROSS UNITED STATES WESTPORT, CONN, DECEMBER 6, 2017 − Connecticut-based medical device innovator Lumendi, LLC reports it has successfully completed more than 100 therapeutic procedures… Continue reading DILUMEN™ EIP COMPLETES 100 THERAPEUTIC PROCEDURES ACROSS UNITED STATES
November 17, 2017
| News | Press Release | Uncategorized
LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS
LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS Primary Study Endpoint Reached with no Serious Adverse Events WESTPORT, CONNECTICUT, November 16, 2017 – Connecticut-based medical device innovator Lumendi, LLC… Continue reading LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS
November 9, 2017
| News | Press Release | Uncategorized
LUMENDI’S DILUMEN Ig™ ENDOLUMENAL INTERVENTIONAL GRASPER FOR MINIMALLY INVASIVE ENDOSCOPIC THERAPIES NOW AVAILABLE IN U.S.
LUMENDI’S DILUMEN Ig™ ENDOLUMENAL INTERVENTIONAL GRASPER FOR MINIMALLY INVASIVE ENDOSCOPIC THERAPIES NOW AVAILABLE IN U.S. Lumendi Submits Premarket Notification to US FDA For DiLumen C2™ and the DiLumen Is™ as Part… Continue reading LUMENDI’S DILUMEN Ig™ ENDOLUMENAL INTERVENTIONAL GRASPER FOR MINIMALLY INVASIVE ENDOSCOPIC THERAPIES NOW AVAILABLE IN U.S.
October 19, 2017
| News | Press Release | Uncategorized
LUMENDI EXPANDS MEDICAL ADVISORY BOARD WITH THREE GLOBAL EXPERTS IN ADVANCED ENDOSCOPY
LUMENDI EXPANDS MEDICAL ADVISORY BOARD WITH THREE GLOBAL EXPERTS IN ADVANCED ENDOSCOPY Dr. Sergey V. Kantsevoy, Professor Alessandro Repici and Professor Kazuki Sumiyama to help guide improvements in endoscopic interventions… Continue reading LUMENDI EXPANDS MEDICAL ADVISORY BOARD WITH THREE GLOBAL EXPERTS IN ADVANCED ENDOSCOPY
October 4, 2017
| News | Press Release
LUMENDI EXPANDS SOCIAL MEDIA PRESENCE
LUMENDI EXPANDS SOCIAL MEDIA PRESENCE WITH NEW YOU TUBE CHANNEL DEDICATED TO ITS DILUMEN™ EIP WESTPORT, CONNECTICUT, October 4, 2017 – Lumendi, LLC (http:/lumendi.com), a wholly owned subsidiary of Lumendi,… Continue reading LUMENDI EXPANDS SOCIAL MEDIA PRESENCE
August 1, 2017
| Press Release
LUMENDI ACHIEVES ISO 13485 CERTIFICATION FOR ITS MEDICAL DEVICES
LUMENDI ACHIEVES ISO 13485 CERTIFICATION FOR ITS MEDICAL DEVICES WESTPORT, CONNECTICUT, August 1, 2017 – Connecticut-based Lumendi, LLC (www.lumendi.com) recently received ISO 13485 certification from BSI, a worldwide recognized leader… Continue reading LUMENDI ACHIEVES ISO 13485 CERTIFICATION FOR ITS MEDICAL DEVICES
May 7, 2017
| Press Release
LUMENDI DILUMEN™ EIP NOW AVAILABLE FOR ENDOLUMENAL THERAPY
LUMENDI DILUMENTM EIP NOW AVAILABLE FOR ENDOLUMENAL THERAPY New Technical Advance in Endolumenal Interventional Platform Expected to Improve Patient Care CHIGAGO, ILLINOIS, May 7, 2017 – Connecticut-based medical device innovator… Continue reading LUMENDI DILUMEN™ EIP NOW AVAILABLE FOR ENDOLUMENAL THERAPY
May 4, 2017
| Press Release
MEDIA ALERT: PHOTO & VIDEO OPPORTUNITIES
DILUMEN™ ENDOLUMENAL INTERVENTION PLATFORM DEMONSTRATED IN WET AND DRY LABS AT DDW BOOTH #1808
MEDIA ALERT: PHOTO & VIDEO OPPORTUNITIES DILUMEN™ ENDOLUMENAL INTERVENTION PLATFORM DEMONSTRATED IN WET AND DRY LABS AT DDW BOOTH #1808 Lumendi LLC will be demonstrating their new DiLumen™ Endolumenal Intervention… Continue reading MEDIA ALERT: PHOTO & VIDEO OPPORTUNITIES
DILUMEN™ ENDOLUMENAL INTERVENTION PLATFORM DEMONSTRATED IN WET AND DRY LABS AT DDW BOOTH #1808
DILUMEN™ ENDOLUMENAL INTERVENTION PLATFORM DEMONSTRATED IN WET AND DRY LABS AT DDW BOOTH #1808
April 29, 2017
| Press Release
LUMENDI EXPANDS TEAM WITH LAURENCE LEFEBVRE
LUMENDI EXPANDS TEAM WITH LAURENCE LEFEBVRE AS SENIOR DIRECTOR PROGRAM MANAGEMENT WESTPORT, CT, May 1, 2017 -- Laurence Lefebvre, from New Rochelle, New York, has joined Connecticut-based medical device innovator… Continue reading LUMENDI EXPANDS TEAM WITH LAURENCE LEFEBVRE
April 5, 2017
| Press Release
LUMENDI EXPANDS WITH FIVE REGIONAL SALES MANAGERS
LUMENDI EXPANDS WITH FIVE REGIONAL SALES MANAGERS WESTPORT, CT, April 4, 2017 -- Connecticut-based medical device innovator Lumendi, LLC has expanded its continually growing employee base with five regional sales… Continue reading LUMENDI EXPANDS WITH FIVE REGIONAL SALES MANAGERS
January 11, 2017
| Press Release
LUMENDI EXPANDS STAFF WITH TWO NEW HIRES: VP SALES AND SENIOR DIRECTOR OF BUSINESS DEVELOPMENT
LUMENDI EXPANDS STAFF WITH TWO NEW HIRES: VP SALES AND SENIOR DIRECTOR OF BUSINESS DEVELOPMENT Industry Veterans James Soares and Yukio Nakajima Join Lumendi’s Endolumenal Interventional Platform Team WESTPORT, CT,… Continue reading LUMENDI EXPANDS STAFF WITH TWO NEW HIRES: VP SALES AND SENIOR DIRECTOR OF BUSINESS DEVELOPMENT
December 13, 2016
| Press Release
LUMENDI RECEIVES FDA CLEARANCE TO MARKET DILUMEN™ FOR ENDOLUMENAL THERAPY
LUMENDI RECEIVES FDA CLEARANCE TO MARKET DILUMEN™ FOR ENDOLUMENAL THERAPY New Endolumenal Interventional Platform Developed by Lumendi with Digestive Disease Leaders at New York-Presbyterian and Weill Cornell Medicine’s MINT Program… Continue reading LUMENDI RECEIVES FDA CLEARANCE TO MARKET DILUMEN™ FOR ENDOLUMENAL THERAPY
September 11, 2016
| Press Release
Weill Cornell Medical College and NewYork-Presbyterian Hospital License Technology to Lumendi, Ltd.
Weill Cornell Medical College and NewYork-Presbyterian Hospital License Technology to Lumendi, Ltd. Start-Up Company Dedicated to Developing and Commercializing Products Aimed At Revolutionizing Gastrointestinal Surgeries NEW YORK —… Continue reading Weill Cornell Medical College and NewYork-Presbyterian Hospital License Technology to Lumendi, Ltd.